According to FutureWise analysis the market for surgical stapling devices in 2023 is US$ 5.35 billion, and is expected to reach US$ 11.09 billion by 2031 at a CAGR of 9.6%.
Surgical stapling devices are used for incision closure or wound closure post-surgery. The acceptance of surgical staplers has experienced an escalation due to the benefits offered by surgical staplers as compared to conventional stitching and suturing techniques. Surgical staples are generally made using plastic, polylactide-polyglycolide copolymer and titanium. The polylactide-polyglycolide copolymer staple is prominently used during plastic surgeries for hiding the scars. As per the data provided by OECD, over 2000,000 caesarean procedures were performed in 2017 in the United Kingdom. Rising number of patients with accident related sport related injuries and growing number of people diagnosed with appalling diseases shall boost the surgical stapling devices market growth. Furthermore, a wide range of products offered by key market players along with a growing acceptance of these products in developed regions shall propel the augmentation of the market.
Advancements in surgical stapler technology shall prominently impact the acceptance of surgical stapling devices amongst healthcare professionals. Furthermore, various nob angles and sizes of these devices has enabled the healthcare personnel in easily performing the laparoscopic surgeries. These advantages are predicted to propel the adoption of these devices in comparison to conventional suturing techniques. For example, the powered surgical staple bolsters the patient during injuries from trauma, whereas urgent wound closure is necessary in preventing the loss of blood. These powered devices perform better in lowering the pain and reducing time. Such advantages provided by these devices shall bolster the market growth.